Pediatrics (System-Integrated)

Pediatric urinary tract infection: workup and follow-up imaging

Clinical Overview and When to Suspect Pediatric UTI

— Infants <3 months: febrile UTI prevalence ~7%; uncircumcised boys have the highest rate (up to 20% in the first 3 months)

— Ages 2–24 months with unexplained fever: prevalence ~5%; girls > boys after infancy

— Beyond age 2: predominantly girls; consider voiding dysfunction, constipation, sexual abuse

— Any infant <2 months with fever ≥38°C — UTI is on the differential along with bacteremia/meningitis

— Unexplained fever ≥39°C in girls <24 months, uncircumcised boys <12 months, circumcised boys <6 months

— Older child with dysuria, frequency, urgency, suprapubic pain, new-onset enuresis, flank pain, or foul-smelling urine

— Failure to thrive, poor feeding, jaundice in neonates

Board pearl: AAP 2011 (reaffirmed) defines UTI in children 2–24 months as both pyuria/bacteriuria on UA and ≥50,000 CFU/mL of a single uropathogen on a catheterized or suprapubic specimen — bag specimens are screening only and never sufficient for diagnosis.

Definition: Bacterial infection of the urinary tract in children, ranging from cystitis (lower) to pyelonephritis (upper, febrile UTI). In Step 3 pediatric practice, the dominant clinical question is whether a febrile infant or young child has a UTI and what imaging follow-up is mandated.

Epidemiology by age and sex:

Most common pathogens: E. coli (~80%), Klebsiella, Proteus (especially boys), Enterococcus, Staph saprophyticus (adolescent girls)

When to suspect:

Risk factors: Vesicoureteral reflux (VUR), constipation, bladder/bowel dysfunction, prior UTI, uncircumcised status, indwelling catheter, neurogenic bladder, posterior urethral valves

Why it matters on Step 3: Missed pyelonephritis → renal scarring → hypertension, CKD, pregnancy complications later in life. The exam tests when to image, what to image with, and when to refer.

Presentation Patterns and Key History

— Nonspecific: fever or hypothermia, irritability, lethargy, poor feeding, vomiting, prolonged or worsening jaundice (classic neonatal UTI clue), failure to thrive

— Often part of a full sepsis workup; UTI here mandates blood culture and LP consideration

— Fever without an identifiable source is the dominant presentation

— Vomiting, fussiness, decreased oral intake, malodorous urine

— Parents may report "crying with urination" or straining

— Classic dysuria, frequency, urgency, suprapubic pain

— Secondary enuresis in a previously toilet-trained child — always check a UA

— Flank or back pain + fever → pyelonephritis

— Hematuria (gross or microscopic)

— Looks like adult cystitis; ask about sexual activity, contraception, and STI exposure (gonorrhea/chlamydia can mimic UTI with sterile pyuria)

— Prior UTIs and prior imaging results

— Voiding pattern: holding urine, infrequent voiding, dysfunctional elimination

— Constipation — a massively underdiagnosed driver of recurrent UTI

— Stream quality in boys (weak/dribbling stream → posterior urethral valves)

— Prenatal ultrasound findings (hydronephrosis)

— Family history of VUR, renal anomalies, or CKD

— Circumcision status

Step 3 management: A toilet-trained child with recurrent UTI and constipation — first intervention is aggressive constipation management (polyethylene glycol, scheduled toileting, fiber) before escalating to prophylactic antibiotics or urology referral. Bowel-bladder dysfunction is the single most modifiable risk factor.

Neonate (0–28 days):

Infant (1–24 months):

Preschool/school-age (2–10 years):

Adolescent:

Critical history elements:

Red flags pointing away from simple UTI: Abdominal mass, hypertension, growth failure, palpable bladder, sacral dimple/hair tuft (occult spinal dysraphism with neurogenic bladder)

Physical Exam Findings and Hemodynamic Assessment

— Fever ≥39°C raises pyelonephritis probability

— Tachycardia out of proportion to fever, hypotension, prolonged capillary refill → urosepsis, escalate immediately

— Hypothermia in a neonate is as worrisome as fever

— Toxic-appearing infant (lethargic, poor tone, weak cry, mottled) → admit, full sepsis workup, empiric IV antibiotics

— Well-appearing but febrile infant <2 months still requires full evaluation

— Suprapubic tenderness (cystitis)

— Costovertebral angle (CVA) tenderness in older children (pyelonephritis) — unreliable <2 years

— Palpable bladder → retention, possible obstruction

— Palpable abdominal/flank mass → hydronephrosis, multicystic dysplastic kidney, or Wilms tumor (alternative dx)

— Circumcision status in boys; phimosis or balanitis

— Labial adhesions in girls (can cause urinary pooling and recurrent UTI)

— Vulvovaginitis, foreign body, signs of sexual abuse

— Meatal stenosis, hypospadias

— Sacral dimple above the gluteal cleft, hair tuft, lipoma, hemangioma → tethered cord/occult dysraphism → neurogenic bladder → image the spine

Key distinction: Pyelonephritis vs cystitis in children — pyelonephritis is defined clinically by fever ≥38°C plus UTI, not by CVA tenderness alone, because young children cannot reliably localize pain. Any febrile UTI in a child <2 years is treated as pyelonephritis and triggers the imaging algorithm.

Board pearl: Blood pressure must be measured and plotted by age/sex/height percentile at every UTI visit — undiagnosed hypertension is a sentinel sign of reflux nephropathy or renal scarring.

Vital signs first:

General appearance:

Abdominal exam:

Genitourinary exam (always perform):

Back/spine exam:

Neurologic: Lower extremity tone, reflexes, gait — abnormalities suggest spinal cord pathology contributing to bladder dysfunction

Growth parameters: Plot height, weight, BP — growth failure or hypertension suggests underlying renal disease (reflux nephropathy, scarring, CKD)

Diagnostic Workup — Urinalysis and Urine Culture

— Not toilet-trained: Catheterized specimen or suprapubic aspiration is the gold standard

— Bag specimen: Acceptable only for screening; a negative bag UA reasonably excludes UTI, but a positive bag specimen must be confirmed by cath or SPA before treatment commitment

— Toilet-trained: Clean-catch midstream

— Leukocyte esterase: Sensitivity ~80%, specificity ~80%

— Nitrites: Specificity >95%, sensitivity only ~50% (infants void frequently, gram-positives don't reduce nitrate) — a positive nitrite is highly specific

— Pyuria: ≥5 WBCs/hpf on centrifuged urine or ≥10 WBC/μL on enhanced UA

— Bacteriuria on Gram stain: Highly suggestive when present

— Catheter or SPA: ≥50,000 CFU/mL of a single uropathogen + pyuria = UTI

— Clean catch: ≥100,000 CFU/mL traditional cutoff

— Mixed flora = contamination, do not treat

— Sterile pyuria: Think partially treated UTI, Kawasaki disease, appendicitis adjacent to bladder, STI (adolescents), viral cystitis (adenovirus), TB

— Asymptomatic bacteriuria — do not treat in healthy children; treat in pregnancy (adolescents) and pre-urologic-instrumentation

— Neonates and toxic infants: CBC, blood culture, CRP/procalcitonin, electrolytes, BUN/Cr, lumbar puncture (concurrent meningitis rate ~1–2% in febrile UTI <1 month)

— Older well-appearing children with cystitis: UA + culture only

CCS pearl: When you order "urinalysis" on a febrile non–toilet-trained infant, also order urine culture by catheterization in the same click — sending only a bag UA wastes a clock cycle and forces a redo if positive. Always pair UA with culture before antibiotics.

Specimen collection (this is the most tested point):

Urinalysis components:

Urine culture thresholds (AAP):

Pitfalls:

Adjunct labs based on age/severity:

Diagnostic Workup — Follow-Up Imaging Algorithm

— Indications (AAP 2011, reaffirmed 2016): All children 2–24 months after their first febrile UTI

— Also obtain after any UTI in: atypical presentation, poor response to 48 h of appropriate antibiotics, recurrent febrile UTI, non–E. coli organism, hypertension, poor growth, family history of renal disease, abnormal voiding

— Timing: Within the acute illness if not improving by 48 h; otherwise outpatient soon after recovery

— Looks for: hydronephrosis, dilated ureters, renal size/echogenicity, bladder wall thickness, posterior urethral valve dilation

— Indicated when:

— RBUS shows hydronephrosis, scarring, or evidence of high-grade VUR or obstructive uropathy

— Recurrent febrile UTI (≥2 febrile UTIs)

— Atypical or complex clinical course

— Not routinely indicated after a single febrile UTI with normal RBUS

— Detects and grades VUR (I–V), identifies posterior urethral valves in boys

— Performed when child is infection-free (typically 2–6 weeks after treatment), with prophylactic antibiotic coverage on the day of study

— Most sensitive for renal cortical scarring and acute pyelonephritis

— Not routine; consider when scarring assessment will change management (e.g., before surgical reflux repair, or to confirm pyelonephritis when diagnosis is uncertain)

— Wait ≥4–6 months after acute infection to distinguish permanent scar from acute inflammation

Board pearl: The "top-down" approach (RBUS + DMSA, then VCUG only if abnormal) is an alternative used in some centers to reduce VCUG exposure, but the AAP-endorsed bottom-up approach (RBUS first, then VCUG selectively) is the Step 3 answer.

Renal/bladder ultrasound (RBUS):

Voiding cystourethrogram (VCUG):

DMSA renal scan (technetium-99m dimercaptosuccinic acid):

CT and MRI: Not first-line for pediatric UTI; reserved for abscess, complex anatomy, or trauma

Risk Stratification and Empiric Management Logic

— <2 months, fever: Admit. Full sepsis workup (blood, urine, CSF). IV empiric antibiotics (ampicillin + gentamicin or ampicillin + cefotaxime).

— 2–24 months, febrile, well-appearing, tolerating PO: Outpatient management with oral antibiotics is acceptable; oral and IV have equivalent outcomes for renal scarring

— 2–24 months, ill-appearing, vomiting, immunocompromised, or known urologic anomaly: Admit for IV therapy

— Older child with cystitis: Outpatient oral antibiotics

— Febrile UTI/pyelonephritis: 7–14 days (typically 10 days)

— Cystitis in older child: 3–5 days acceptable

— Local E. coli resistance patterns (avoid amoxicillin/ampicillin alone — resistance >50%)

— Prior antibiotic exposure

— Renal function

— Allergies

— Re-review culture sensitivities

— Obtain RBUS to look for abscess, obstruction, or pyonephrosis

— Consider broader-spectrum agent and admission

Step 3 management: A 9-month-old with febrile UTI improving on day 2 of oral cefixime — continue oral therapy to complete the 10-day course, schedule outpatient RBUS, and arrange follow-up. Do not switch to IV, do not extend duration, and do not repeat culture if improving.

Key distinction: Hospitalization criteria are clinical (toxicity, age <2 months, inability to tolerate PO, immunocompromise, urologic anomaly) — not the diagnosis of pyelonephritis itself. Many well-appearing children with pyelonephritis are managed entirely as outpatients.

Decision tree by age/appearance:

Duration of therapy:

Choice influenced by:

Repeat urine culture during treatment: Not routinely needed if clinical improvement by 48 h

If no improvement at 48 h:

Pharmacotherapy — First-Line Antibiotic Regimens

— Cephalexin 50–100 mg/kg/day divided q6–8h (cystitis, first-line)

— Cefixime 8 mg/kg/day once daily (excellent for pyelonephritis)

— Cefpodoxime 10 mg/kg/day divided BID

— Trimethoprim-sulfamethoxazole 8–10 mg/kg/day of TMP component divided BID — only if local E. coli TMP-SMX resistance <20% and not used recently

— Amoxicillin-clavulanate — acceptable but higher GI side effects

— Nitrofurantoin — cystitis only (does not achieve renal parenchymal levels; do NOT use for pyelonephritis or in <1 month old)

— Ceftriaxone 50–75 mg/kg/day (avoid in neonates <28 days with hyperbilirubinemia — displaces bilirubin from albumin → kernicterus risk)

— Cefotaxime preferred in neonates

— Ampicillin + gentamicin — covers Enterococcus and gram-negatives, classic neonatal regimen

— Piperacillin-tazobactam or cefepime for resistant organisms or known urologic anomalies

— Fluoroquinolones (ciprofloxacin) — reserved for resistant organisms or Pseudomonas; not first-line in children due to musculoskeletal concerns, but acceptable when alternatives are inadequate

— Tetracyclines — avoid <8 years

— Aminoglycoside monotherapy — monitor renal function and levels

Board pearl: Ampicillin monotherapy and amoxicillin are inadequate empiric choices for pediatric UTI because community E. coli resistance frequently exceeds 50%. A first-generation cephalosporin or cefixime is the typical Step 3 answer for outpatient empiric therapy.

Empiric oral options (cystitis or well-appearing febrile UTI):

Empiric IV options (hospitalized or toxic):

Step-down to oral once afebrile 24–48 h and tolerating PO, guided by sensitivities

Agents to avoid or use cautiously:

Adjuncts: Antipyretics (acetaminophen, ibuprofen), hydration. Phenazopyridine is not routinely used in young children.

Procedures and Subspecialty Interventions

— Small-bore feeding tube (5 Fr) or pediatric catheter

— Sterile technique, lubricant, retract foreskin gently in uncircumcised boys

— Discard first few drops, collect midstream from the catheterized flow

— Used when catheterization fails or in neonates with phimosis/labial adhesions

— Ultrasound guidance preferred; bladder must be full

— Catheter inserted, bladder filled with contrast, fluoroscopic images during voiding

— Continue antibiotic prophylaxis around the procedure to prevent procedural UTI

— Radiation exposure modest; contrast-enhanced voiding urosonography (ceVUS) is an emerging radiation-free alternative

— Endoscopic injection (Deflux) — subureteric injection for grade II–IV VUR

— Ureteral reimplantation — for high-grade VUR (IV–V), breakthrough UTIs on prophylaxis, or worsening scarring

— Posterior urethral valve ablation — neonatal emergency in boys with bladder distension, hydronephrosis, and elevated creatinine

— Pyeloplasty for ureteropelvic junction obstruction

— Percutaneous nephrostomy for obstructed pyelonephritis or pyonephrosis

— Abscess drainage (>3 cm or not responding to antibiotics)

— Reduces UTI risk ~10-fold in boys <1 year

— Consider as risk-reduction in boys with recurrent UTI or high-grade VUR after shared decision-making

CCS pearl: When a febrile UTI is not improving by 48 h on appropriate antibiotics, order RBUS immediately to look for obstruction or abscess — these are surgical issues, not antibiotic failures. Consult urology and consider IV broad-spectrum coverage while imaging is obtained.

Bladder catheterization for diagnosis:

Suprapubic aspiration:

VCUG procedure logistics:

Surgical interventions (urology referral):

Drainage procedures:

Circumcision:

Special Populations — Renal Impairment and Comorbid Conditions

— Adjust antibiotic dose for GFR (especially aminoglycosides, TMP-SMX, cephalosporins)

— Lower threshold for hospitalization and IV therapy

— UTI in CKD accelerates renal decline — aggressive treatment and nephrology comanagement

— High rate of asymptomatic bacteriuria — do not treat unless symptomatic (fever, change in continence, hematuria, increased spasticity, foul urine)

— Clean intermittent catheterization (CIC) is the cornerstone of management

— Treat symptomatic UTI based on culture; expect resistant and polymicrobial organisms

— Screen periodically for upper tract changes with RBUS

— Broaden empiric coverage; include fungal coverage (candiduria) when prolonged catheterization, antibiotic exposure, or neutropenia

— Admit and consult ID

— Higher resistance, Pseudomonas, Enterococcus

— Empiric piperacillin-tazobactam or cefepime ± vancomycin

— Remove or change catheter when feasible

— Increased UTI risk; papillary necrosis can complicate pyelonephritis

— Maintain hydration, monitor renal function

— Higher pyelonephritis and emphysematous complications risk; assess glycemic control

Step 3 management: A 10-year-old with myelomeningocele on CIC has a screening urine showing 100,000 CFU E. coli but is asymptomatic and afebrile — do not treat. Treating asymptomatic bacteriuria in neurogenic bladder selects for resistance without changing outcomes; reinforce CIC technique and hygiene instead.

Children with chronic kidney disease:

Neurogenic bladder (myelomeningocele, spinal cord injury, tethered cord):

Immunocompromised hosts (transplant, malignancy, primary immunodeficiency):

Children with indwelling catheters or recent instrumentation:

Sickle cell disease:

Diabetes (adolescents):

Special Populations — Neonates and Adolescents

— Any febrile UTI is treated as part of a neonatal sepsis evaluation: blood culture, urine (cath), LP

— Concurrent bacteremia rate: ~10%; concurrent meningitis ~1–2%

— IV antibiotics for full course; many practitioners continue IV for 7–10 days then oral for total 10–14 days

— RBUS routinely; VCUG often obtained at this age because of higher likelihood of structural anomaly

— Avoid ceftriaxone in jaundiced neonates — use cefotaxime or ampicillin + gentamicin

— Most centers admit; selected well-appearing infants ≥2 months with reliable follow-up may be discharged on oral therapy after initial parenteral dose

— Evaluate for dysfunctional voiding and constipation (Bristol stool chart, voiding diary)

— Behavioral measures: scheduled voiding q2–3h, double voiding, fluid intake, treat constipation aggressively

— Consider urodynamic studies if refractory

— Sexually active: screen for chlamydia and gonorrhea if dysuria with sterile pyuria

— Postcoital voiding counseling

— Pregnancy testing before imaging that uses radiation or contrast; pregnant adolescents need treatment of asymptomatic bacteriuria (unlike non-pregnant patients) — typically nitrofurantoin (avoid near term), cephalexin, or fosfomycin

— Recurrent cystitis: consider postcoital prophylaxis or self-start therapy

Board pearl: Asymptomatic bacteriuria is treated in two pediatric scenarios only: pregnancy and before urologic instrumentation. In all other children — including those with neurogenic bladder, VUR, or prior UTI — it should not be treated.

Neonates (<28 days):

Infants 1–3 months:

Toilet-trained children with recurrent UTI:

Adolescents:

Female anatomic considerations: Labial adhesions in toddlers — topical estrogen or betamethasone if causing recurrent UTI

Complications and Adverse Outcomes

— Urosepsis — especially in neonates and infants with obstruction; can progress rapidly to shock

— Renal/perinephric abscess — suspect when fever persists >48–72 h on appropriate antibiotics; diagnose with RBUS or CT; drain if >3 cm

— Pyonephrosis — pus in an obstructed collecting system; surgical emergency requiring nephrostomy drainage

— Acute kidney injury from sepsis, dehydration, or obstruction

— Bacteremia — 5–10% of febrile UTIs in infants

— Renal scarring — develops in ~10–15% after first febrile UTI; risk factors are delayed treatment, VUR (especially grade III–V), recurrent infection, non–E. coli pathogens, and young age

— Reflux nephropathy → hypertension (most common long-term sequela), proteinuria, CKD, ESRD

— Pregnancy complications later in life: preeclampsia, pyelonephritis of pregnancy, preterm birth in women with reflux nephropathy

— Growth impairment in bilateral scarring

— C. difficile from broad-spectrum antibiotics

— Antibiotic resistance from inappropriate prophylaxis

— VCUG-induced UTI if no periprocedural prophylaxis

— Contrast reactions (rare in fluoroscopic VCUG)

Key distinction: Acute pyelonephritis on DMSA vs permanent scar — acute photopenia on DMSA during illness may resolve completely; permanent scars are diagnosed only on DMSA imaging obtained ≥4–6 months after the infection. This timing is a favorite testing point.

Board pearl: Annual blood pressure measurement is mandatory in any child with documented renal scarring — hypertension is the earliest and most common detectable sequela of reflux nephropathy.

Acute complications:

Long-term complications (the real Step 3 focus):

Iatrogenic complications:

Psychosocial: Toilet-training regression, school absences, family anxiety

When to Escalate — Admission, Consults, and ICU

— Age <2 months with any febrile UTI

— Toxic appearance, hemodynamic instability, or sepsis criteria

— Inability to tolerate oral intake or medications

— Persistent vomiting

— Concern for adherence or unreliable follow-up

— Immunocompromise

— Known urologic anomaly or prior surgery

— Failure of outpatient therapy (no improvement at 48–72 h)

— Suspected complicated UTI (abscess, obstruction, stones)

— Septic shock requiring vasopressors

— Respiratory failure

— Multi-organ dysfunction

— Neonates with urosepsis often require ICU-level monitoring

— Pediatric urology:

— Hydronephrosis, VUR grade III–V, posterior urethral valves, recurrent febrile UTI, breakthrough UTI on prophylaxis, abnormal anatomy on imaging

— Pediatric nephrology:

— Renal scarring with hypertension or proteinuria, declining GFR, bilateral renal disease, suspected reflux nephropathy

— Pediatric ID: Multidrug-resistant organisms, recurrent infection workup, suspected immunodeficiency

— Pediatric surgery / interventional radiology: Abscess drainage, nephrostomy

— Child protection team: If sexual abuse is a concern in unexplained UTI or STI in young child

— Neonatal urosepsis requiring level III NICU

— Complex urologic anomalies requiring pediatric urology unavailable locally

CCS pearl: In the CCS case, escalation comes from trajectory, not from diagnosis label. If your "stable" febrile UTI patient develops tachycardia, hypotension, or persistent fever after 48 h, move to inpatient/ICU location, broaden antibiotics, order RBUS, and consult urology — all in the same clock advance.

Admit for inpatient management when:

ICU criteria:

Subspecialty consults:

Transfer to tertiary center:

Key Differentials — Other Genitourinary Conditions

— Dysuria from external burning, not true cystitis

— Discharge, erythema, no fever, normal UA (may have a few WBCs)

— Causes: poor hygiene, bubble baths, irritants, occasionally Streptococcus pyogenes or pinworms

— Sexually transmitted: Chlamydia, Gonorrhea, Trichomonas

— Sterile pyuria with dysuria; NAAT testing

— Adenovirus (especially serotypes 11, 21) — gross hematuria, dysuria, afebrile or low-grade fever, negative bacterial culture

— BK virus in transplant patients

— Cyclophosphamide/ifosfamide chemotherapy

— Severe flank pain, hematuria, often afebrile unless infected stone

— Risk factors: hypercalciuria, ketogenic diet, cystinuria, urinary stasis

— Imaging: ultrasound first, low-dose non-contrast CT if needed

— Weak stream, palpable bladder, hydronephrosis on prenatal US or after UTI

— Diagnosis: VCUG is definitive

— Often discovered after first febrile UTI; graded I–V on VCUG

— Hematuria + hypertension + edema; dysmorphic RBCs, RBC casts, proteinuria — not pyuria

— Intermittent flank pain, palpable mass, may present after UTI

Key distinction: Adenoviral hemorrhagic cystitis vs bacterial UTI — both have dysuria and pyuria, but adenovirus typically presents with gross hematuria, negative urine culture, and resolves spontaneously in 1–2 weeks. No antibiotics needed; supportive care only.

Vulvovaginitis (preschool girls):

Urethritis (adolescents):

Hemorrhagic cystitis:

Nephrolithiasis:

Posterior urethral valves (boys):

Vesicoureteral reflux:

Glomerulonephritis:

Hydronephrosis from UPJ obstruction:

Key Differentials — Non-GU Mimics

— A retrocecal or pelvic appendix can irritate the bladder, producing sterile pyuria and dysuria

— Look for migrating periumbilical → RLQ pain, anorexia, focal tenderness, Rovsing sign

— Imaging: ultrasound or CT

— Prolonged fever, sterile pyuria, plus conjunctivitis, mucosal changes, rash, extremity changes, cervical lymphadenopathy

— Echocardiogram for coronary aneurysms; IVIG + aspirin

— Can present with abdominal pain, fever, vomiting mimicking pyelonephritis

— Auscultate carefully; CXR if persistent fever without source

— Unexplained dysuria, genital trauma, STI in a prepubertal child mandates evaluation

— Mandatory reporting to child protective services

— Polyuria mimicking frequency; glucosuria on UA without infection

— Check serum glucose

— Massively impacted stool causes urinary frequency, retention, and recurrent UTI

— Plain abdominal film may show fecal loading

— Nocturnal perineal itching, vulvovaginitis, occasional UTI symptoms in young girls

Board pearl: Sterile pyuria in a child with prolonged fever ≥5 days — think Kawasaki disease before any other diagnosis. Missed Kawasaki leads to coronary artery aneurysms; this is one of the highest-stakes mimics on the exam.

Appendicitis:

Kawasaki disease:

Pneumonia (lower lobe):

Sexual abuse:

Diabetes (new-onset):

Constipation:

Pinworms (Enterobius):

Anxiety/voiding dysfunction: Functional daytime urinary frequency in school-age children — diurnal frequency without nocturia, normal UA, self-resolves

Munchausen by proxy: Recurrent "UTIs" with inconsistent cultures, caretaker-collected specimens

Secondary Prevention and Long-Term Plan

— RIVUR trial: Continuous antibiotic prophylaxis (TMP-SMX) in children with VUR (grades I–IV) reduced recurrent febrile UTI by ~50% but did not reduce renal scarring; doubled antibiotic resistance

— Reasonable in: grade III–V VUR, recurrent febrile UTIs, while awaiting VCUG, dysfunctional voiding with breakthrough UTI

— Not routine after first febrile UTI with normal imaging

— Agents: TMP-SMX 2 mg/kg/day (TMP component) or nitrofurantoin 1–2 mg/kg/day, given as a single nightly dose

— Treat constipation aggressively — PEG 3350, fiber, scheduled toileting; this is the single highest-yield intervention for recurrent UTI

— Timed voiding every 2–3 hours; double voiding

— Adequate hydration to maintain dilute urine

— Proper wiping technique front-to-back in girls

— Avoid bubble baths, harsh soaps, tight underwear

— Postcoital voiding for sexually active adolescents

— Cotton underwear, breathable clothing

— Teach signs of UTI to recognize early presentation

— When to seek care (fever, dysuria, change in voiding pattern)

— Importance of completing antibiotic course

Step 3 management: After a second febrile UTI in a 3-year-old girl, RBUS shows mild hydronephrosis and VCUG shows grade III VUR — start daily prophylactic TMP-SMX, refer to pediatric urology, treat constipation, and schedule a DMSA scan in 4–6 months to assess for scarring.

Prophylactic antibiotics — narrow indications:

Behavioral and lifestyle measures (apply to all):

Circumcision counseling for uncircumcised boys with recurrent UTI or high-grade VUR

Vaccinations: Routine immunizations including rotavirus (preserve volume status)

Cranberry products: Limited evidence in children; not formally recommended

Probiotics: Insufficient evidence

Family counseling:

Follow-Up, Monitoring, and Counseling Cadence

— Phone or clinic check at 48–72 hours to confirm clinical improvement

— In-person visit at end of treatment course not always required for uncomplicated cystitis; required for febrile UTI in young children

— Repeat urine culture not routine if clinical improvement; obtain only if symptoms persist

— RBUS within 2 weeks of acute illness (or during admission if not improving)

— VCUG if indicated, scheduled when child is asymptomatic, on prophylaxis

— DMSA at 4–6 months post-infection if scarring assessment is needed

— Annual blood pressure, height, weight

— Annual urinalysis for proteinuria (early reflux nephropathy marker)

— Periodic serum creatinine and electrolytes in moderate–severe disease

— Repeat RBUS every 1–2 years to monitor renal growth

— Repeat VCUG every 1–2 years to assess for VUR resolution (~30% resolve annually for grades I–III)

— Nephrology referral for scarring with HTN, proteinuria, or declining function

— Most VUR resolves spontaneously; surgery is not always needed

— Emphasize bowel-bladder dysfunction as the modifiable risk factor

— Recognize and act on early UTI symptoms

— Long-term implications: cardiovascular risk from hypertension, renal function preservation, future pregnancy considerations

— Adolescents with VUR or CKD transition to adult urology/nephrology around age 18–21

— Hand-off summary should include imaging history, GFR trend, BP trend, prior surgeries

CCS pearl: After completing UTI treatment, schedule the RBUS and the follow-up visit before the patient leaves your clinic — failure to do this is the most common reason imaging is missed and long-term renal sequelae are detected late.

Acute follow-up after treatment:

Imaging follow-up:

Longitudinal surveillance in children with VUR or scarring:

Counseling families:

Transition of care:

Ethical, Legal, and Patient Safety Considerations

— Recurrent or unexplained UTIs in prepubertal children, especially with genital trauma, STIs, or behavioral red flags, raise concern for sexual abuse

— Physicians are mandated reporters — report to Child Protective Services on reasonable suspicion; you do not need to confirm abuse before reporting

— Document findings objectively; use a forensic exam team when available

— VCUG carries small radiation exposure and is psychologically distressing for children; discuss alternatives (ceVUS) and rationale

— Antibiotic prophylaxis: discuss the RIVUR data — recurrence prevention without scarring reduction; involve family in the prophylaxis-versus-watchful-waiting decision

— Surgical reflux correction is elective; ensure parents understand observation is reasonable for low-grade VUR

— Avoid empiric broad-spectrum agents when narrow ones suffice

— Do not treat asymptomatic bacteriuria

— Avoid extended prophylaxis without indication

— Discharge from hospital after pyelonephritis without RBUS scheduled → missed structural anomaly

— Failure to transmit positive culture results from urgent care to PCP → undertreated UTI

— Use closed-loop communication: confirm test results reviewed, follow-up scheduled, prescriptions filled

— STI testing and treatment can be performed without parental consent in most US states under minor consent laws

— Discuss confidentiality limits up front (cannot guarantee if billed through parental insurance)

— Recurrent UTI clinics, urology referrals, and imaging require access — assist with referrals, interpreter services, and transportation

Board pearl: A positive bag urine culture is never sufficient to diagnose UTI; treating based on it constitutes a patient-safety lapse (overdiagnosis, unnecessary antibiotics, unnecessary imaging). Always confirm with catheterized specimen before committing to diagnosis.

Mandatory reporting and child protection:

Informed consent and shared decision-making:

Antibiotic stewardship:

Transitions of care risk (high-yield Step 3 theme):

Confidentiality in adolescents:

Health equity:

Documentation: Always document specimen collection method (cath vs bag) — affects validity of diagnosis and downstream imaging decisions

High-Yield Associations and Rapid-Fire Facts

Key distinction: VCUG vs DMSA — VCUG diagnoses reflux (anatomy, dynamic), DMSA diagnoses scarring (parenchyma, function). Different questions, different tools.

Most common pathogen at all ages: E. coli (~80%)

Proteus UTI: Associated with struvite stones (alkaline urine, urease producer), more common in boys

Staph saprophyticus: Sexually active adolescent girls

Group B Strep UTI in a pregnant adolescent: Treat and add intrapartum prophylaxis

Uncircumcised boys <1 year: 10× UTI risk vs circumcised

First febrile UTI 2–24 months: Get RBUS, VCUG only if abnormal or recurrent (AAP)

VUR grading: I (ureter only) → V (massive dilation, tortuosity, loss of papillary impressions)

Spontaneous VUR resolution: ~30%/year for grades I–III; rare for grade V

DMSA timing for scarring: ≥4–6 months post-infection

Highest scarring risk: Delayed antibiotic initiation, high-grade VUR, recurrent infection, non-E. coli organism

Posterior urethral valves: Boy with weak stream, palpable bladder, bilateral hydronephrosis — VCUG diagnostic, cystoscopic ablation curative

Prune belly syndrome: Absent abdominal muscles + cryptorchidism + urinary tract anomalies

Sterile pyuria differential: Partially treated UTI, Kawasaki, appendicitis, STI, TB, adenovirus, nephrolithiasis

Nitrofurantoin: Cystitis only; avoid in pyelonephritis, neonates, G6PD deficiency

Ceftriaxone: Avoid in jaundiced neonates

Asymptomatic bacteriuria treatment indications in pediatrics: Pregnancy, pre-urologic instrumentation — that's it

RIVUR trial takeaway: Prophylaxis ↓ recurrence by ~50%, no scar reduction, ↑ resistance

Hypertension is the most common long-term sequela of renal scarring

Constipation is the most modifiable risk factor for recurrent pediatric UTI

Bag specimen: Useful only if negative; positive needs confirmation by cath

Board Question Stem Patterns

"A 10-month-old uncircumcised boy presents with 2 days of fever to 39.2°C without a clear source. UA from a catheter specimen shows +LE, +nitrites, 30 WBC/hpf." → Diagnosis: UTI; next step: urine culture, empiric oral cephalosporin or cefixime, RBUS after recovery.

"A 14-month-old girl recovered from first febrile UTI. RBUS shows mild left hydronephrosis." → Next step: VCUG.

"A 3-year-old has had three febrile UTIs in 6 months. RBUS normal." → Next step: VCUG (recurrent febrile UTI alone is an indication).

"A bag specimen from a 9-month-old shows pyuria and positive nitrites." → Next step: catheterized specimen before starting antibiotics.

"A 5-year-old girl with recurrent cystitis, hard stools every 4 days, secondary enuresis." → Best initial therapy: aggressive constipation treatment and timed voiding.

"An 18-day-old with fever 38.5°C, jaundice, poor feeding, cath UA with pyuria." → Admit, full sepsis workup including LP, IV ampicillin + gentamicin or cefotaxime (NOT ceftriaxone), RBUS during admission.

"Febrile UTI on day 3 of appropriate IV ceftriaxone, still febrile." → Order RBUS to evaluate for abscess or obstruction.

"5-year-old with 6 days fever, conjunctivitis, rash, sterile pyuria." → Kawasaki disease; echocardiogram, IVIG.

"Newborn boy with palpable bladder, weak stream, bilateral hydronephrosis." → VCUG; urology consult.

"Routine UA in 8-year-old with myelomeningocele on CIC, asymptomatic." → Do not treat.

Step 3 management: Pattern recognition shortcut — if the question asks "next best step" after a first febrile UTI in a child <24 months, the answer is almost always renal-bladder ultrasound. If RBUS is abnormal or it's a recurrent febrile UTI, the answer pivots to VCUG.

Stem 1 — The febrile infant:

Stem 2 — Post-UTI imaging:

Stem 3 — Recurrent febrile UTI:

Stem 4 — Bag vs cath:

Stem 5 — Constipation and UTI:

Stem 6 — The neonate:

Stem 7 — Persistent fever:

Stem 8 — Sterile pyuria + prolonged fever:

Stem 9 — Posterior urethral valves:

Stem 10 — Asymptomatic bacteriuria, neurogenic bladder:

One-Line Recap

Every child 2–24 months with a first febrile UTI needs a catheter-confirmed diagnosis, age-appropriate antibiotics, and a renal-bladder ultrasound — with VCUG reserved for abnormal RBUS, recurrent febrile UTI, or atypical course — because the entire point of the workup is to detect and prevent the renal scarring that drives lifelong hypertension and CKD.

Board pearl: The three highest-yield Step 3 traps in pediatric UTI are (1) treating a positive bag specimen, (2) using ceftriaxone in a jaundiced neonate, and (3) forgetting to schedule the RBUS at discharge — avoiding all three earns you the points and protects the kidney.

Diagnosis: Catheterized or SPA urine with pyuria + ≥50,000 CFU/mL of a single uropathogen; bag specimens screen only.

Empiric therapy: Oral cephalexin or cefixime for well-appearing children; IV ampicillin + gentamicin or cefotaxime (not ceftriaxone in neonates) for <2 months or toxic; 7–14 days for febrile UTI, 3–5 days for cystitis. Avoid nitrofurantoin for pyelonephritis.

Imaging: RBUS after first febrile UTI in 2–24 months; VCUG if RBUS abnormal, recurrent febrile UTI, atypical course; DMSA at ≥4–6 months to evaluate scarring when management depends on it.

Long-term: Treat constipation and bowel-bladder dysfunction (most modifiable risk factor); prophylactic antibiotics for VUR III–V or recurrent febrile UTI (RIVUR — reduces recurrence, not scarring); annual BP and UA in any child with documented scarring; never treat asymptomatic bacteriuria outside of pregnancy and pre-instrumentation.